NRGN and Alzheimer disease: Brain tissues of patients with AD exhibit decreased synaptic proteins such as growth-associated protein 43 (GAP43), neurogranin, synaptotagmins, Rab3A, and synaptosome-associated protein 25 (SNAP25).